Legend Biotech Corporation
LEGN | NASDAQ
$18.53
+$0.92 (+5.22%)
At close: Sep 21, 2026, 4:00 PM ET
$18.48
-$0.05 (-0.27%)
Pre-market:
Sep 22, 2026, 4:01 AM ET
Market Data
Market Cap $3.26B
Enterprise Value $2.74B
Beta 0.40
Average Volume 2.57M
Shares Outstanding (Diluted) 193.8M
Shares Change YoY 5.25%
Institutional Ownership 51.66%
Exchange NASDAQ
ISIN US52490G1022
Price Performance
Price Change 1M -14.4%
Price Change 3M -36.8%
Price Change 6M 5.3%
Price Change YTD -13.8%
Price Change 1Y -45.6%
Price Change 3Y -70.7%
Price Change 5Y -60.7%
1M CAGR (ann.) -8.7%
1Y CAGR (ann.) -48.9%
5Y CAGR (ann.) -14.0%
All-Time CAGR -11.1%
Valuation
PE Ratio -37.06
Forward PE 28.90
PEG Ratio -0.43
Forward PEG 0.01
PS Ratio 2.70
Forward PS 1.90
PB Ratio 2.79
P/FCF Ratio -14.58
P/Adj. FCF Ratio -12.82
P/OCF Ratio -18.91
EV/Sales 2.16
EV/EBIT -63.60
EV/EBITDA -378.33
EV/FCF -11.66
Earnings Yield -2.7%
FCF Yield -6.9%
Adj. FCF Yield -7.8%
Financial Health
Net Cash $808.2M
Total Debt $278.2M
Cash & Short-Term Investments $964.6M
Total Assets $1.75B
Current Ratio 3.04
Quick Ratio 2.94
Debt / Equity Ratio 0.23
Debt / EBITDA -38.40
Debt / FCF -1.18
OCF / Debt -0.66
Interest Coverage -3.34
Altman Z-Score 3.38
Piotroski F-Score 3
Margins & Profitability
Gross Profit Margin 56.6%
Operating Profit Margin -4.4%
EBITDA Margin -0.6%
Net Profit Margin -7.2%
FCF Margin -18.5%
Adj. FCF Margin -21.0%
SBC / Revenue 2.5%
SBC Impact (per share) -13.8%
Returns
Return on Assets -5.2%
Return on Equity -8.7%
Return on Invested Capital -3.7%
Return on Capital Employed -4.2%
Return on Tangible Assets -5.2%
Historical Growth (CAGR)
Revenue CAGR 3Y 97.7%
Revenue CAGR 5Y 70.3%
Revenue CAGR 10Y N/A
EPS CAGR 3Y 41.6%
EPS CAGR 5Y 32.0%
EPS CAGR 10Y N/A
FCF CAGR 3Y -15.3%
FCF CAGR 5Y 2.4%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 20
EPS Growth Next 3Y 96.7%
Revenue Growth Next 3Y 20.6%
Earnings Date Nov 10, 2026
EPS Estimate (next Q) $0.02
EPS Growth Est (next Q) -118.2%
Revenue Est (next Q) $361.43M
Revenue Growth Est (next Q) 32.7%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $56.14
Price Target Upside 203.0%
Cash Flow
Operating Cash Flow $-183.1M
Free Cash Flow $-234.99M
Adj. Free Cash Flow $-267.31M
FCF Per Share -$1.37
OCF Per Share -$0.98
OCF/S Ratio -14.4%
Income Statement
Revenue $1.27B
Gross Profit $719.24M
Operating Income $-56.15M
EBITDA $-7.24M
Net Income $-91.6M
EPS (Diluted) -$0.50
Revenue / Employee $397.28K
Profit / Employee $-28.63K
Employees 3,200
Add to Watchlist
Select watchlists to add or remove LEGN